| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cancer susceptibility 11 | 0.641 | 0.577 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2016 | 2016 | |||||||||
|
EGFR antisense RNA 1 | 0.722 | 0.192 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
disease | 0.700 | None | 1.000 | 1 | 1 | 2012 | 2020 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.120 | None | 1.000 | 1 | 2 | 2016 | 2018 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.700 | None | 0.977 | 3 | 6 | 2008 | 2020 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.650 | None | 1.000 | 1 | 1 | 2013 | 2018 | ||||||||
|
EPH receptor A5 | 0.626 | 0.615 | 7.3E-05 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2005 | 2005 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.967 | 3 | 2 | 1990 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 5 | 2010 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.500 | None | 0.987 | 2 | 6 | 1989 | 2020 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.170 | None | 1.000 | 1 | 2 | 2004 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.923 | 1 | 9 | 1990 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.700 | None | 0.978 | 5 | 7 | 1990 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.200 | None | 0.933 | 1 | 4 | 1996 | 2016 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.420 | None | 1.000 | 1 | 2 | 2010 | 2016 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.991 | 1 | 81 | 1992 | 2019 | ||||||||
|
beta-2-microglobulin | 0.447 | 0.846 | 0.56 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2016 | 2016 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2016 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
disease | 0.120 | None | 1.000 | 1 | 2 | 2015 | 2017 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.430 | None | 1.000 | 1 | 1 | 2014 | 2016 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
disease | 0.650 | None | 0.857 | 2 | 6 | 2008 | 2019 | ||||||||
|
A-Raf proto-oncogene, serine/threonine kinase | 0.619 | 0.654 | 0.96 |
|
disease | 0.410 | None | 1.000 | 2 | 2 | 2014 | 2016 | ||||||||
|
protein phosphatase 2 scaffold subunit Aalpha | 0.588 | 0.577 | 0.98 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2014 | 2019 |